J. Savary

1.6k total citations · 1 hit paper
24 papers, 1.3k citations indexed

About

J. Savary is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, J. Savary has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Genetics. Recurrent topics in J. Savary's work include Enzyme function and inhibition (5 papers), Protein Structure and Dynamics (2 papers) and Renal cell carcinoma treatment (2 papers). J. Savary is often cited by papers focused on Enzyme function and inhibition (5 papers), Protein Structure and Dynamics (2 papers) and Renal cell carcinoma treatment (2 papers). J. Savary collaborates with scholars based in France, Monaco and Cyprus. J. Savary's co-authors include Bernard Escudier, Sylvie Négrier, Christine Lasset, Christine Chevreau, Alain Ravaud, Thierry Philip, Jean‐Yves Douillard, Mireille Mousseau, J Pény and A. Mercatello and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and FEBS Letters.

In The Last Decade

J. Savary

23 papers receiving 1.2k citations

Hit Papers

Recombinant Human Interleukin-2, Recombinant Human Interf... 1998 2026 2007 2016 1998 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
    1998 742 citations Sylvie Négrier, Bernard Escudier et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Savary France 15 687 512 511 293 196 24 1.3k
J Bellmunt Spain 14 967 1.4× 330 0.6× 751 1.5× 434 1.5× 420 2.1× 31 1.9k
Alton B. Kremer United States 11 850 1.2× 660 1.3× 551 1.1× 405 1.4× 93 0.5× 13 1.4k
Julia Wilkerson United States 20 713 1.0× 501 1.0× 608 1.2× 284 1.0× 188 1.0× 44 1.8k
Edith Huland Germany 25 851 1.2× 281 0.5× 392 0.8× 149 0.5× 447 2.3× 90 1.6k
Rose J. Papac United States 19 377 0.5× 373 0.7× 647 1.3× 164 0.6× 342 1.7× 49 1.5k
Gunnar Wagenius Sweden 23 600 0.9× 417 0.8× 873 1.7× 164 0.6× 196 1.0× 80 1.5k
Lyly Le Canada 13 544 0.8× 622 1.2× 465 0.9× 281 1.0× 109 0.6× 22 1.3k
James L. Freddo United States 13 568 0.8× 563 1.1× 397 0.8× 294 1.0× 121 0.6× 27 1.2k
Ulrika Harmenberg Sweden 23 1.0k 1.5× 693 1.4× 736 1.4× 375 1.3× 208 1.1× 57 1.7k
Tinya J. Abrams United States 12 824 1.2× 936 1.8× 835 1.6× 322 1.1× 94 0.5× 17 2.1k

Countries citing papers authored by J. Savary

Since Specialization
Citations

This map shows the geographic impact of J. Savary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Savary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Savary more than expected).

Fields of papers citing papers by J. Savary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Savary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Savary. The network helps show where J. Savary may publish in the future.

Co-authorship network of co-authors of J. Savary

This figure shows the co-authorship network connecting the top 25 collaborators of J. Savary. A scholar is included among the top collaborators of J. Savary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Savary. J. Savary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacquin, Jean-Philippe, Cyrus Chargari, Hubert Orfeuvre, et al.. (2011). Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients. American Journal of Clinical Oncology. 35(1). 18–21. 11 indexed citations
2.
Farhi, David, et al.. (2011). Étude prospective des onychomycoses des pieds en France : prévalence, aspect clinique, impact et prise en charge en médecine générale. Journal de Mycologie Médicale. 21(4). 266–272. 10 indexed citations
3.
Penault‐Llorca, Frédérique, Anne Cayre, Laurent Arnould, et al.. (2006). Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?. Oncology Reports. 16(6). 1173–9. 32 indexed citations
4.
Savary, J., Ortonne Jp, & S. Aractingi. (2005). The right dose in the right place: an overview of current prescription, instruction and application modalities for topical psoriasis treatments. Journal of the European Academy of Dermatology and Venereology. 19(s3). 14–17. 20 indexed citations
5.
6.
Serin, D., et al.. (2004). Parcours de femmes 2001. ONCOLOGIE. 6(7). 494–504. 8 indexed citations
7.
Pivot, Xavier, Christine Chevreau, Didier Cupissol, et al.. (2002). Phase II Trial of Paclitaxel–Epirubicin in Patients With Recurrent Soft-Tissue Sarcoma. American Journal of Clinical Oncology. 25(6). 561–564. 14 indexed citations
8.
Pivot, Xavier, L. Cals, Didier Cupissol, et al.. (2000). Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck. Oncology. 60(1). 66–71. 33 indexed citations
9.
Escudier, Bernard, Christine Chevreau, Christine Lasset, et al.. (1999). Cytokines in Metastatic Renal Cell Carcinoma: Is It Useful to Switch to Interleukin-2 or Interferon After Failure of a First Treatment?. Journal of Clinical Oncology. 17(7). 2039–2039. 66 indexed citations
10.
Négrier, Sylvie, Bernard Escudier, Christine Lasset, et al.. (1998). Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma. New England Journal of Medicine. 338(18). 1272–1278. 742 indexed citations breakdown →
11.
Thiesse, Philippe, L. Ollivier, Sylvie Négrier, et al.. (1997). Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer.. Journal of Clinical Oncology. 15(12). 3507–3514. 138 indexed citations
12.
13.
14.
Vandewalle, B., J. Savary, M O Vilain, et al.. (1987). Establishment and characterization of a new cell line (VHB-1) derived from a primary breast carcinoma. Journal of Cancer Research and Clinical Oncology. 113(6). 550–558. 16 indexed citations
15.
Bismuth, J, et al.. (1986). Triiodothyronine (T3)-Induced Down-Regulation of the Nuclear T3Receptor in Mouse Preadipocyte Cell Lines*. Endocrinology. 119(5). 2360–2367. 17 indexed citations
16.
Savary, J., et al.. (1970). Données physiques comparées sur les anhydrases carboniques érythrocytaires bovines A et B. Biochimica et Biophysica Acta (BBA) - Protein Structure. 221(2). 367–369. 16 indexed citations
17.
Savary, J., et al.. (1969). Données physiques comparées sur les anhydrases carboniques érythrocytaires humaines A et B. Biochimica et Biophysica Acta (BBA) - Enzymology. 171(2). 363–365. 20 indexed citations
18.
Lissitzky, Serge, et al.. (1968). Structure sous‐unitaire de la thyroglobuline de mouton. European Journal of Biochemistry. 4(4). 464–471. 53 indexed citations
19.
Savary, J., et al.. (1966). [Hydrodynamic study of sheep thyroglobulin].. PubMed. 48(6). 815–28. 1 indexed citations
20.
Biserte, G, et al.. (1957). [Biochemistry of the amniotic fluid: protein complexes, organic and ketone acids].. PubMed. 37(11). 429–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Bellmunt Breakdown of academic impact, for papers by Alton B. Kremer Breakdown of academic impact, for papers by Julia Wilkerson Breakdown of academic impact, for papers by Edith Huland Breakdown of academic impact, for papers by Rose J. Papac Breakdown of academic impact, for papers by Gunnar Wagenius Breakdown of academic impact, for papers by Lyly Le Breakdown of academic impact, for papers by James L. Freddo Breakdown of academic impact, for papers by Ulrika Harmenberg Breakdown of academic impact, for papers by Tinya J. Abrams
Rankless by CCL
2026